Osborne Clarke has advised Quintiles (NYSE:Q) the largest global provider of biopharmaceutical development and commercial outsourcing services, on the European aspects of its agreement to acquire Novella Clinical (Novella).

Janita Good, Partner and Head of Life-Science and Healthcare in the UK led the Osborne Clarke team. Janita was assisted by Corporate Associate Director Thomas Colmer, Tax Partner Erika Jupe, Recruitment Consultant Frances Lewis, Employment Senior Associate Anna Chamberlain, Dispute and Resolution Associate Director David Kendall, Pensions Associate Isobel Dyson, Tax Partner Karen Cooper and Competition Partner Simon Neill.